Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00754 |
LY6G6D Protein, Human, Recombinant (His & Strep-II)
C6orf23,MEGT1,Protein Ly6 |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His & Strep-II) is ex... | |||
TMPK-00752 |
LY6G6D Protein, Human, Recombinant (hFc)
G6D,MEGT1,C6orf23,NG25,Protei... |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (hFc) is expressed in ... | |||
TMPK-01332 |
LY6G6D Protein, Cynomolgus, Recombinant (His)
Ly6-D,C6orf23,G6 |
Cynomolgus | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Cynomolgus, Recombinant (His) is expresse... | |||
TMPK-00753 |
LY6G6D Protein, Human, Recombinant (His)
C6orf23,Ly6-D,NG25,G... |
Human | HEK293 Cells |
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy. LY6G6D Protein, Human, Recombinant (His) is expressed in ... |